Quality CareFind out why Mayo Clinic is the right place for your health care. Make an appointment.
Meet the StaffFind a directory of doctors and departments at all Mayo Clinic campuses. Visit now.
Research and Clinical TrialsSee how Mayo Clinic research and clinical trials advance the science of medicine and improve patient care. Explore now.
Visit Our SchoolsEducators at Mayo Clinic train tomorrow’s leaders to deliver compassionate, high-value, safe patient care. Choose a degree.
Professional ServicesExplore Mayo Clinic's many resources and see jobs available for medical professionals. Get updates.
Philanthropy at Mayo ClinicYour support accelerates powerful innovations in patient care, research and education. Give today.
Search Results 1-10 of 22 for Bioavailability
Bioequivalence & Food Effect Study in Patients With Solid Tumor or Hematologic Malignancies - Mayo Clinic Overview Study type Interventional Study phase I Study IDs Study type Interventional Describes the nature of a clinical study. Types include: Ob...
Little is known about the therapeutic efficacy of increasing nitric oxide bioavailability in the context of renal stone formation.
Study IDs Site IRB Rochester, Minnesota: 12-005860 NCT ID: NCT01867255 Sponsor Protocol Number: 12-005860 About this study The purpose of the study is to determine whether a significant and predictable change in bioavailability of ex...
A secondary objective of this study is to evaluate the comparative bioavailability of treprostinil between two formulations of inhaled therapy. more information --> More information Publications Publications are currently not availab...
A blood test is the only way to diagnose a low testosterone level or a reduction in the bioavailability of testosterone.
Our overall hypothesis is that the aging process can be regulated by PAPP-A, which degrades inhibitory IGFBP-4, thereby increasing IGF-I bioavailability.
SSI-4 has excellent oral bioavailability and is well-tolerated with long-term daily dosing.
In this project, we aim to identify agents that are selective inhibitors for pancreatic lipases and have good bioavailability.
The genetic variations were categorized into four main metabolizer phenotypes: Poor Intermediate Normal Ultrarapid Ultrarapid metabolizers potentially have lower bioavailability of the medication and thus possibly lower efficacy.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic.
Mayo Clinic is a nonprofit organization and proceeds from Web advertising help support our mission. Mayo Clinic does not endorse any of the third party products and services advertised.
A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.org," "Mayo Clinic Healthy Living," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.